Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 9, 2024npj VaccinesOpen Access

Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development

View Full Paper
Ask AI
Bookmark
Share

Authors

SCSaurabh ChughCentre National de la Recherche ScientifiqueRBRitika Kar BahalThe University of Western AustraliaRDRohan DhimanNational Institute of Technology Rourkela

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chugh et al. (2024) studied this question.

synapsesocial.com/papers/68e74cd0b6db6435876c5535https://doi.org/10.1038/s41541-024-00834-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis1992 · 453 citations
  2. 2Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines1988 · 253 citations
  3. 3HspX‐mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule2012 · 67 citations
  4. 4Identification of Immunodominant Antigens during Infection with <i>Mycobacterium tuberculosis</i>1992 · 96 citations
  5. 5DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8 + T cell responses2014 · 16 citations